The Biggest FemTech Funding Rounds Of 2025
Femtech represents a growing industry dedicated to women's health technology, encompassing products, software, and services that assist users in tracking and managing health metrics. The global femtech market was valued at $9.12 billion in 2025, with a…
Femtech represents a growing industry dedicated to women's health technology, encompassing products, software, and services that assist users in tracking and managing health metrics. The global femtech market was valued at $9.12 billion in 2025, with a significant number of femtech unicorns emerging worldwide.
FemTech, short for female technology, refers to tech-driven solutions focused on women's health, including areas like menstrual health, fertility, menopause, pregnancy, and sexual wellness. The sector has seen mainstream adoption, with tech companies developing various health-optimizing solutions.
Notable FemTech Funding Rounds in 2025
In October, Oura raised over $900 million in a Series E funding round. Oura's technology supports health tracking by measuring basal body temperature and menstruation, aiding in vital health monitoring.
Round: Series E Post-Raise Valuation: $11 billion Led by: Fidelity Management & Research Company
German biotech startup Tubulis raised €344 million in October across multiple funding rounds. The company is focusing on developing antibody drugs targeting antigens in ovarian cancer and lung adenocarcinomas.
Future Family secured $400 million to provide financial solutions for fertility treatments, offering low-interest loans for procedures such as IVF and egg freezing, alongside online support services.
The global femtech market was valued at $9.12 billion in 2025, with a significant number of femtech unicorns emerging worldwide.
Round: Financing Led by: Clear Haven Capital Management
Hims & Hers, a telehealth platform, raised $1 billion through debt financing to support international expansion and AI investment. The platform includes services for women's health, focusing on skin care, birth control, and sexual health.
Conceivable Life Sciences: $50 Million (September)
Conceivable Life Sciences aims to enhance IVF effectiveness using AI and robotics. The company raised $50 million to advance research and improve IVF outcomes globally.
Round: Series A Led by: ARTIS ventures, Stride, ACME ventures
Mercy BioAnalytics: $59 Million (September)
Mercy BioAnalytics focuses on early cancer detection, particularly for ovarian and lung cancers, through blood-based tests. The company aims to improve ovarian cancer diagnosis with their recent funding.
Visby Medical raised $55 million to launch an FDA-approved at-home STI test for women, offering reliable, lab-grade testing solutions.
Round: Financing Led by: Catalio Capital Management
Diana Health, a network of women's health practices, secured funding to expand its personalized care services both in-person and online, partnering with hospitals to enhance healthcare delivery.
Round: Series C Led by: HealthQuest Capital
Based on reporting by techround.co.uk.